Recce Pharmaceuticals advances R327 Gel towards Phase 3 after promising Phase II trial

Recce Pharmaceuticals Limited has announced significant success in its Phase II trial of RECCE 327 topical gel (R327G), a synthetic anti-infective designed to treat acute ... Read More